DK0970103T3 - Antigenstagent steroider med floureret 17alfa-alkylkæde - Google Patents

Antigenstagent steroider med floureret 17alfa-alkylkæde

Info

Publication number: DK0970103T3
Authority: DK; Denmark
Prior art keywords: 17alpha; steroids; antigenic; fluorinated; alkyl chain
Prior art date: 1997-02-07

Application number

DK98905419T

Other languages

Danish (da)

English (en)

Inventor

Wolfgang Schwede

Arwed Cleve

Ulrich Klar

Guenter Neef

Kristof Chwalisz

Martin Schneider

Ulrike Fuhrmann

Holger Hess-Stumpp

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-02-07

Filing date

1998-02-09

Publication date

2002-07-22

1998-02-09 Application filed by Schering Ag filed Critical Schering Ag

2002-07-22 Application granted granted Critical

2002-07-22 Publication of DK0970103T3 publication Critical patent/DK0970103T3/da

Links

230000000890 antigenic effect Effects 0.000 title 1
150000003431 steroids Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Toxicology (AREA)
Diabetes (AREA)
Pregnancy & Childbirth (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK98905419T 1997-02-07 1998-02-09 Antigenstagent steroider med floureret 17alfa-alkylkæde DK0970103T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19706061A DE19706061A1 (de)	1997-02-07	1997-02-07	Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
PCT/EP1998/000752 WO1998034947A1 (de)	1997-02-07	1998-02-09	ANTIGESTAGEN WIRKSAME STEROIDE MIT FLUORIERTER 17α-ALKYLKETTE

Publications (1)

Publication Number	Publication Date
DK0970103T3 true DK0970103T3 (da)	2002-07-22

Family

ID=7820508

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98905419T DK0970103T3 (da)	1997-02-07	1998-02-09	Antigenstagent steroider med floureret 17alfa-alkylkæde

Country Status (35)

Country	Link
US (4)	US6316432B1 (pl)
EP (1)	EP0970103B1 (pl)
JP (1)	JP4324249B2 (pl)
KR (1)	KR100511815B1 (pl)
CN (2)	CN1246865A (pl)
AR (1)	AR010887A1 (pl)
AT (1)	ATE216397T1 (pl)
AU (1)	AU742834B2 (pl)
BG (1)	BG63875B1 (pl)
BR (1)	BR9807667A (pl)
CA (1)	CA2280041C (pl)
CL (1)	CL2004001191A1 (pl)
CZ (1)	CZ296328B6 (pl)
DE (2)	DE19706061A1 (pl)
DK (1)	DK0970103T3 (pl)
EA (1)	EA003092B1 (pl)
EE (1)	EE03831B1 (pl)
ES (1)	ES2175673T3 (pl)
HK (1)	HK1040718B (pl)
HU (1)	HUP0000968A3 (pl)
ID (1)	ID22643A (pl)
IL (1)	IL131226A (pl)
IS (1)	IS2190B (pl)
MY (1)	MY118508A (pl)
NO (1)	NO313554B1 (pl)
NZ (1)	NZ336989A (pl)
PL (1)	PL191808B1 (pl)
PT (1)	PT970103E (pl)
SI (1)	SI0970103T1 (pl)
SK (1)	SK283155B6 (pl)
TR (1)	TR199901855T2 (pl)
TW (1)	TW499434B (pl)
UA (1)	UA66783C2 (pl)
WO (1)	WO1998034947A1 (pl)
ZA (1)	ZA98985B (pl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19706061A1 (de) *	1997-02-07	1998-08-13	Schering Ag	Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE10049736A1 (de) *	2000-09-29	2002-04-18	Jenapharm Gmbh	17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE10051609A1 (de) *	2000-10-18	2002-05-02	Schering Ag	Hemmung der Wachstumsfaktorabhängigkeit von Tumorzellen
SK4702003A3 (en) *	2000-10-18	2004-01-08	Schering Ag	Use of antiprogestins for the induction of apoptosis in a cell
CA2423017C (en) *	2000-10-18	2009-01-06	Bayer Schering Pharma Aktiengesellschaft	Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases
IL154974A0 (en) *	2000-10-18	2003-10-31	Schering Ag	Inhibition of the growth factor dependency of tumor cells
UY26966A1 (es) *	2000-10-18	2002-06-20	Schering Ag	Uso de antiprogestinas para la inducción de apoptosis en una célula
UY26965A1 (es) *	2000-10-18	2002-06-20	Schering Ag	Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas
IL156729A0 (en) *	2001-01-09	2004-02-08	Schering Ag	The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
US20020143000A1 (en) *	2001-01-09	2002-10-03	Christa Hegele-Hartung	Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
UY27301A1 (es) *	2001-05-25	2003-02-28	Schering Ag	Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
US20030013694A1 (en) *	2001-05-25	2003-01-16	Jens Hoffmann	Use and compositions of antiprogestins for treatment of prostate diseases
DE10159217A1 (de)	2001-11-27	2003-06-05	Schering Ag	17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
DE10221034A1 (de)	2002-05-03	2003-11-20	Schering Ag	17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE50301507D1 (de) *	2002-05-03	2005-12-01	Schering Ag	17a-FLUORALKYL-11BETA-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
US20040242551A1 (en) *	2003-05-28	2004-12-02	Schering Ag	Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
PL1663978T3 (pl)	2003-07-23	2008-04-30	Bayer Healthcare Llc	Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
US7593347B2 (en) *	2003-12-29	2009-09-22	Intel Corporation	Method and apparatus to exchange channel information
EP1862468A1 (de)	2006-06-02	2007-12-05	Bayer Schering Pharma Aktiengesellschaft	Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
MY150763A (en)	2006-10-24	2014-02-28	Repros Therapeutics Inc	Compositions and methods for suppressing endometrial proliferation
DE102006054535A1 (de) *	2006-11-15	2008-05-21	Bayer Schering Pharma Aktiengesellschaft	Progesteronrezeptorantagonisten
US20080268041A1 (en) *	2007-04-23	2008-10-30	Jens Hoffmann	Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases
CA2683809A1 (en) *	2007-04-23	2008-10-30	Bayer Schering Pharma Aktiengesellschaft	Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen
TWI539953B (zh)	2008-04-28	2016-07-01	瑞波若斯治療學公司	用於治療乳癌之組成物和方法
EP2123279A1 (de) *	2008-05-14	2009-11-25	Bayer Schering Pharma Aktiengesellschaft	Sequentielle Verabreichung von 20,20,21,21,21-Pentafluor-17-hydroxy-1 1beta-[4-(hydroxyacetyl) phenyl]-19-nor-17alpha-pregna-4,9-dien-3-on und einem oder mehreren Gestagenen zur Behandlung gynäkologischer Erkrankungen
US20100087402A1 (en) *	2008-09-29	2010-04-08	Vivus, Inc.	Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
DE102009034367A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de)	2009-07-21	2011-02-10	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) *	2009-07-21	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
DE102010007719A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
MX2012010327A (es)	2010-03-22	2012-11-16	Repros Therapeutics Inc	Composiciones y metodos para la administracion no toxica de antiprogestinas.
DE102010030538A1 (de)	2010-06-25	2011-12-29	Bayer Schering Pharma Aktiengesellschaft	6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
DE102011004899A1 (de)	2011-03-01	2012-09-06	Bayer Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
US20130029953A1 (en) *	2011-07-28	2013-01-31	Klaus Nickisch	Progesterone antagonists
DE102011087987A1 (de)	2011-12-08	2013-06-13	Bayer Intellectual Property Gmbh	6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
PL2983671T4 (pl)	2013-04-11	2019-04-30	Bayer Pharma AG	Postać dawkowania antagonisty receptora progesteronowego
US9096641B2 (en)	2013-06-05	2015-08-04	Evestra, Inc.	Imidazolyl progesterone antagonists
EP2868323A1 (en)	2013-11-03	2015-05-06	Flamina Holding AG	A pharmaceutical composition or group of compositions for inhibiting autocrine HCG production in adult human cells
EP2868321A1 (en) *	2013-11-03	2015-05-06	Flamina Holding AG	A composition or group of compositions for inhibiting autocrine HCG production in adult human cells
MA42103A (fr)	2015-05-18	2018-03-28	Bayer Pharma AG	Régime posologique à base de modulateur sélectif du récepteur de la progestérone (rpm)
EP3214092A1 (en)	2016-03-04	2017-09-06	Bayer Pharma Aktiengesellschaft	Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE310541C (pl) *	1915-12-19	1919-01-30
ZA8231B (en) *	1981-01-09	1982-11-24	Roussel Uclaf	New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2639045B2 (fr)	1982-03-01	1994-07-29	Roussel Uclaf	Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
US5064821A (en) *	1982-11-18	1991-11-12	Trustees Of Tufts College	Method and compositions for overcoming tetracycline resistance within living cells
FR2598421B1 (fr) *	1986-05-06	1988-08-19	Roussel Uclaf	Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
US5272140A (en) *	1987-01-23	1993-12-21	Akzo N.V.	11-aryl steroid derivatives
DE3723788A1 (de) *	1987-07-16	1989-01-26	Schering Ag	11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3733478A1 (de)	1987-10-01	1989-04-13	Schering Ag	Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
JP2785023B2 (ja) *	1987-12-30	1998-08-13	ルセル―ユクラフ	１７α位置を置換された１７β―ＯＨ―１９―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
EP0369881A1 (fr) *	1988-11-16	1990-05-23	Roussel-Uclaf	Nouveaux produits dérivés de la structure 3-céto delta-4,9 19-nor stéroides et leur application comme médicaments
DE3921059A1 (de) *	1989-06-23	1991-01-10	Schering Ag	11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
CN1055929C (zh) *	1993-09-20	2000-08-30	中国科学院上海有机化学研究所	三氟甲基甾体化合物及其制备方法
DE19706061A1 (de) *	1997-02-07	1998-08-13	Schering Ag	Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette

1997
- 1997-02-07 DE DE19706061A patent/DE19706061A1/de not_active Withdrawn
1998
- 1998-02-06 MY MYPI98000482A patent/MY118508A/en unknown
- 1998-02-06 ZA ZA9800985A patent/ZA98985B/xx unknown
- 1998-02-07 TW TW087101642A patent/TW499434B/zh not_active IP Right Cessation
- 1998-02-09 AU AU61005/98A patent/AU742834B2/en not_active Ceased
- 1998-02-09 DK DK98905419T patent/DK0970103T3/da active
- 1998-02-09 PT PT98905419T patent/PT970103E/pt unknown
- 1998-02-09 UA UA99094999A patent/UA66783C2/xx unknown
- 1998-02-09 DE DE59803856T patent/DE59803856D1/de not_active Expired - Lifetime
- 1998-02-09 CN CN98802361A patent/CN1246865A/zh active Pending
- 1998-02-09 TR TR1999/01855T patent/TR199901855T2/xx unknown
- 1998-02-09 ES ES98905419T patent/ES2175673T3/es not_active Expired - Lifetime
- 1998-02-09 JP JP53378598A patent/JP4324249B2/ja not_active Expired - Fee Related
- 1998-02-09 CA CA002280041A patent/CA2280041C/en not_active Expired - Fee Related
- 1998-02-09 WO PCT/EP1998/000752 patent/WO1998034947A1/de not_active Ceased
- 1998-02-09 EP EP98905419A patent/EP0970103B1/de not_active Expired - Lifetime
- 1998-02-09 ID IDW990831A patent/ID22643A/id unknown
- 1998-02-09 HU HU0000968A patent/HUP0000968A3/hu unknown
- 1998-02-09 EE EEP199900339A patent/EE03831B1/xx not_active IP Right Cessation
- 1998-02-09 AT AT98905419T patent/ATE216397T1/de active
- 1998-02-09 AR ARP980100532A patent/AR010887A1/es unknown
- 1998-02-09 SI SI9830200T patent/SI0970103T1/xx unknown
- 1998-02-09 PL PL334878A patent/PL191808B1/pl not_active IP Right Cessation
- 1998-02-09 BR BR9807667-1A patent/BR9807667A/pt active Search and Examination
- 1998-02-09 IL IL13122698A patent/IL131226A/en not_active IP Right Cessation
- 1998-02-09 KR KR10-1999-7007098A patent/KR100511815B1/ko not_active Expired - Fee Related
- 1998-02-09 SK SK1038-99A patent/SK283155B6/sk not_active IP Right Cessation
- 1998-02-09 NZ NZ336989A patent/NZ336989A/en not_active IP Right Cessation
- 1998-02-09 EA EA199900644A patent/EA003092B1/ru not_active IP Right Cessation
- 1998-02-09 CZ CZ0280599A patent/CZ296328B6/cs not_active IP Right Cessation
1999
- 1999-07-26 BG BG103603A patent/BG63875B1/bg unknown
- 1999-08-04 IS IS5147A patent/IS2190B/is unknown
- 1999-08-06 NO NO19993811A patent/NO313554B1/no not_active IP Right Cessation
2000
- 2000-03-01 US US09/516,359 patent/US6316432B1/en not_active Expired - Fee Related
- 2000-09-25 CN CNB001290150A patent/CN1202120C/zh not_active Expired - Fee Related
2001
- 2001-10-18 US US09/978,689 patent/US6503895B2/en not_active Expired - Fee Related
2002
- 2002-04-08 HK HK02102580.0A patent/HK1040718B/zh not_active IP Right Cessation
- 2002-11-27 US US10/304,742 patent/US6806263B2/en not_active Expired - Fee Related
2004
- 2004-05-20 CL CL200401191A patent/CL2004001191A1/es unknown
- 2004-09-24 US US10/948,652 patent/US7148213B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
UA66783C2 (en)	2004-06-15
US6503895B2 (en)	2003-01-07
ZA98985B (en)	1999-08-03
EE9900339A (et)	2000-02-15
SK283155B6 (sk)	2003-03-04
TW499434B (en)	2002-08-21
PT970103E (pt)	2002-09-30
JP4324249B2 (ja)	2009-09-02
KR20000070835A (ko)	2000-11-25
SK103899A3 (en)	2000-05-16
EA199900644A1 (ru)	2000-04-24
BG63875B1 (bg)	2003-04-30
EP0970103A1 (de)	2000-01-12
PL334878A1 (en)	2000-03-27
CZ296328B6 (cs)	2006-02-15
CA2280041C (en)	2007-10-23
HUP0000968A3 (en)	2001-03-28
ES2175673T3 (es)	2002-11-16
EP0970103B1 (de)	2002-04-17
BR9807667A (pt)	2000-02-15
MY118508A (en)	2004-11-30
CL2004001191A1 (es)	2005-03-28
DE59803856D1 (de)	2002-05-23
DE19706061A1 (de)	1998-08-13
NO993811L (no)	1999-10-04
HUP0000968A2 (hu)	2000-10-28
IL131226A (en)	2004-12-15
WO1998034947A1 (de)	1998-08-13
CN1324802A (zh)	2001-12-05
CA2280041A1 (en)	1998-08-13
IL131226A0 (en)	2001-01-28
US6316432B1 (en)	2001-11-13
US6806263B2 (en)	2004-10-19
CN1202120C (zh)	2005-05-18
AR010887A1 (es)	2000-07-12
NZ336989A (en)	2001-04-27
US7148213B2 (en)	2006-12-12
US20050080060A1 (en)	2005-04-14
NO993811D0 (no)	1999-08-06
JP2001510479A (ja)	2001-07-31
IS5147A (is)	1999-08-04
US20030134834A1 (en)	2003-07-17
TR199901855T2 (xx)	2000-04-21
BG103603A (en)	2000-06-30
ID22643A (id)	1999-12-02
CN1246865A (zh)	2000-03-08
EE03831B1 (et)	2002-08-15
ATE216397T1 (de)	2002-05-15
HK1040718B (zh)	2005-12-09
NO313554B1 (no)	2002-10-21
KR100511815B1 (ko)	2005-09-05
AU6100598A (en)	1998-08-26
AU742834B2 (en)	2002-01-10
EA003092B1 (ru)	2002-12-26
IS2190B (is)	2007-01-15
HK1040718A1 (en)	2002-06-21
US20020045774A1 (en)	2002-04-18
SI0970103T1 (en)	2002-10-31
PL191808B1 (pl)	2006-07-31
CZ280599A3 (cs)	2000-01-12

Publication	Publication Date	Title
EE03831B1 (et)	2002-08-15	Antigestageenselt toimivad fluoritud 17a-alküülahelaga steroidid
DE69822808D1 (de)	2004-05-06	Strömungsmaschine
NO20002135D0 (no)	2000-04-26	Reflectometer
ID24430A (id)	2000-07-20	Turunan-turunan benzamidina
BR9711853A (pt)	1999-08-24	Vacinas
DE69708118D1 (de)	2001-12-13	Kettenrad
DE59706490D1 (de)	2002-04-04	Kettenrad
ID19474A (id)	1998-07-16	Turunan tiazola
DE59905487D1 (de)	2003-06-12	Handlauf
FI974269A0 (fi)	1997-11-18	Radiosaendare-mottagarestruktur med tvao frekvensomraoden
DE69735807D1 (de)	2006-06-08	Wendelantenne mit gebogenen segmenten
ID18095A (id)	1998-02-26	Turunan tetrahidrokinolin
BR9710202A (pt)	1999-08-10	Combustor
DE59707844D1 (de)	2002-09-05	Stanzniet
ID20780A (id)	1999-03-04	Rantai kancing tarik
DK0898969T3 (da)	2005-01-17	Neospora-vaccine
NO991372D0 (no)	1999-03-22	Trinn med reflektorer
NO974125D0 (no)	1997-09-08	N-benzylazoliumderivater
DE59701251D1 (de)	2000-04-20	Brüstungsleiste
ID19573A (id)	1998-07-23	Herbisida selektif berbasiskan
DE69516530D1 (de)	2000-05-31	Hülse
KR970056926U (ko)	1997-11-10	성기능 강화체인
BR9706069A (pt)	1999-03-02	Dispositivo elétrico estático
KR950030602U (ko)	1995-11-20	난간 고정구
KR950030601U (ko)	1995-11-20	난간 고정구